Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 200
Filtrar
1.
Eur Rev Med Pharmacol Sci ; 23(22): 10169-10176, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31799689

RESUMO

OBJECTIVE: To explore the effect of bradykinin on rats with thromboangiitis obliterans (TAO) through the phosphatidylinositol 3-hydroxy kinase/protein kinase B (PI3K/Akt) signaling pathway. MATERIALS AND METHODS: The female Wistar rats were injected with lauric acid via the femoral artery to establish the TAO model, and they were randomly divided into control group (healthy rats), model group (TAO rats) and bradykinin group (TAO rats injected with bradykinin B2 receptor-specific inhibitor). The control was set in each group before the operation. The level of serum bradykinin in each group was detected via enzyme-linked immunosorbent assay (ELISA), and the reactive oxygen species (ROS) level, Caspase-3 activity and PI3K/Akt protein concentration in vascular tissues were measured via ELISA, Western blotting, ROS assay, and Caspase-3 activity assay, respectively. Moreover, the specific therapeutic mechanism of bradykinin was analyzed. RESULTS: In control group, the intima of the lower extremity venous tissues was smooth, the extima had no evident changes, and there was no inflammatory cell invasion around the arteries and veins. In model group, there was massive inflammatory cell invasion into the lower extremity venous tissues. In bradykinin group, fibrosis and atrophy occurred in venous tissues, the extima was thickened without fibrosis, and there was phagocytosis of neutrophils and mononuclear macrophages around the arteries and veins, as well as massive inflammatory infiltration. The PI3K/Akt protein concentration in lower extremity venous tissues was the highest in control group and the lowest in bradykinin group, and there were statistically significant differences (p<0.01). At 24 h after administration of doxorubicin (DOX), the level of ROS in lower extremity venous tissues was higher in bradykinin group than that in model group (p<0.05), and it was also higher in model group than that in control group (p<0.05). Besides, the activity of Caspase-3 in lower extremity venous tissues was significantly increased in bradykinin group compared with that in model group and control group, while it was slightly higher in model group than that in control group (p<0.05). CONCLUSIONS: The low expression of bradykinin can promote TAO in rats by the mechanism that it inhibits the PI3K/Akt signaling pathway to raise the oxidative stress level, thereby aggravating TAO.


Assuntos
Antagonistas de Receptor B2 da Bradicinina/administração & dosagem , Bradicinina/sangue , Transdução de Sinais/efeitos dos fármacos , Tromboangiite Obliterante/tratamento farmacológico , Vasodilatadores/administração & dosagem , Animais , Apoptose/efeitos dos fármacos , Antagonistas de Receptor B2 da Bradicinina/farmacologia , Feminino , Ácidos Láuricos/efeitos adversos , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Ratos , Ratos Wistar , Espécies Reativas de Oxigênio/metabolismo , Tromboangiite Obliterante/induzido quimicamente , Tromboangiite Obliterante/metabolismo , Vasodilatadores/farmacologia
2.
Blood ; 133(10): 1152-1163, 2019 03 07.
Artigo em Inglês | MEDLINE | ID: mdl-30591525

RESUMO

The plasma proteins factor XII (FXII) and prekallikrein (PK) undergo reciprocal activation to the proteases FXIIa and kallikrein by a process that is enhanced by surfaces (contact activation) and regulated by the serpin C1 inhibitor. Kallikrein cleaves high-molecular-weight kininogen (HK), releasing the vasoactive peptide bradykinin. Patients with hereditary angioedema (HAE) experience episodes of soft tissue swelling as a consequence of unregulated kallikrein activity or increased prekallikrein activation. Although most HAE cases are caused by reduced plasma C1-inhibitor activity, HAE has been linked to lysine/arginine substitutions for Thr309 in FXII (FXII-Lys/Arg309). Here, we show that FXII-Lys/Arg309 is susceptible to cleavage after residue 309 by coagulation proteases (thrombin and FXIa), resulting in generation of a truncated form of FXII (δFXII). The catalytic efficiency of δFXII activation by kallikrein is 15-fold greater than for full-length FXII. The enhanced rate of reciprocal activation of PK and δFXII in human plasma and in mice appears to overwhelm the normal inhibitory function of C1 inhibitor, leading to increased HK cleavage. In mice given human FXII-Lys/Arg309, induction of thrombin generation by infusion of tissue factor results in enhanced HK cleavage as a consequence of δFXII formation. The effects of δFXII in vitro and in vivo are reproduced when wild-type FXII is bound by an antibody to the FXII heavy chain (HC; 15H8). The results contribute to our understanding of the predisposition of patients carrying FXII-Lys/Arg309 to angioedema after trauma, and reveal a regulatory function for the FXII HC that normally limits PK activation in plasma.


Assuntos
Fator XII/química , Fator XIa/química , Angioedema Hereditário Tipo III/sangue , Angioedema Hereditário Tipo III/genética , Angioedemas Hereditários , Animais , Arginina/química , Coagulação Sanguínea , Bradicinina/sangue , Catálise , Proteína Inibidora do Complemento C1/química , Fator XIIa/química , Células HEK293 , Humanos , Cininogênios/sangue , Lisina/química , Camundongos , Camundongos Endogâmicos C57BL , Calicreína Plasmática/química , Pré-Calicreína/química , Ligação Proteica , Proteínas Recombinantes/química , Propriedades de Superfície , Trombina/genética
3.
Surgery ; 165(1): 158-165, 2019 01.
Artigo em Inglês | MEDLINE | ID: mdl-30415870

RESUMO

BACKGROUND: Sudden massive release of serotonin, histamine, kallikrein, and bradykinin is postulated to cause an intraoperative carcinoid crisis. The exact roles of each of these possible agents, however, remain unknown. Optimal treatment will require an improved understanding of the pathophysiology of the carcinoid crisis. METHODS: Carcinoid patients with liver metastases undergoing elective abdominal operations were studied prospectively, using intraoperative, transesophageal echocardiography, pulmonary artery catheterization, and intraoperative blood collection. Serotonin, histamine, kallikrein, and bradykinin levels were analyzed by enzyme-linked immunosorbent assay. RESULTS: Of 46 patients studied, 16 had intraoperative hypotensive crises. Preincision serotonin levels were greater in patients who had crises (1,064 vs 453 ng/mL, P = .0064). Preincision hormone profiles were otherwise diverse. Cardiac function on transesophageal echocardiography during the crisis was normal, but intracardiac hypovolemia was observed consistently. Pulmonary artery pressure decreased during crises (P = .025). Linear regression of preincision serotonin levels showed a positive relationship with mid-crisis cardiac index (r = 0.73, P = .017) and a negative relationship with systemic vascular resistance (r=-0.61, P = .015). There were no statistically significant increases of serotonin, histamine, kallikrein, or bradykinin levels during the crises. CONCLUSION: The pathophysiology of carcinoid crisis appears consistent with distributive shock. Hormonal secretion from carcinoid tumors varies widely, but increased preincision serotonin levels correlate with crises and with hemodynamic parameters during the crises. Statistically significant increases of serotonin, histamine, kallikrein, or bradykinin during the crises were not observed.


Assuntos
Hipotensão/fisiopatologia , Hipovolemia/fisiopatologia , Síndrome do Carcinoide Maligno/fisiopatologia , Artéria Pulmonar/fisiopatologia , Serotonina/sangue , Bradicinina/sangue , Tumor Carcinoide/fisiopatologia , Tumor Carcinoide/cirurgia , Ecocardiografia Transesofagiana , Feminino , Histamina/sangue , Humanos , Neoplasias Intestinais/fisiopatologia , Neoplasias Intestinais/cirurgia , Complicações Intraoperatórias , Calicreínas/sangue , Neoplasias Hepáticas/secundário , Neoplasias Pulmonares/fisiopatologia , Neoplasias Pulmonares/cirurgia , Masculino , Síndrome do Carcinoide Maligno/sangue , Pessoa de Meia-Idade , Complicações Pós-Operatórias , Estudos Prospectivos
4.
APMIS ; 126(12): 892-898, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30397964

RESUMO

Activation of the contact system generates bradykinin from high-molecular-weight kininogen and has been suggested to participate in the pathophysiology of sepsis. To test this, we prospectively measured bradykinin and high-molecular-weight kininogen levels in a cohort of sepsis patients requiring intensive care. From 29 patients meeting criteria for sepsis or septic shock according to Sepsis-3, blood was sampled within 24 h and on the fourth day following admittance to intensive care. Patients planned for neurosurgery served as matched controls. Sequential organ failure assessment score and 90-day mortality was registered. Bradykinin levels (median [interquartile range]) were lower in sepsis patients (79 [62-172] pg/ml) compared to controls (130 [86-255] pg/ml, p < 0.025) and did not correlate with mortality or severity of circulatory derangement. High-molecular-weight kininogen levels were lower in sepsis patients (1.6 [0.8-4.8] densitometry units) compared to controls (4.4 [2.9-7.7] densitometry units, p < 0.001), suggesting previous contact system activation. High-molecular-weight kininogen levels were lower in non-survivors than survivors (p = 0.003) and negatively correlated to severity of circulatory derangement. We conclude that a role for bradykinin in later stages of severe sepsis must be challenged. Low high-molecular-weight kininogen concentrations suggest that the decrease in bradykinin is due to substrate depletion.


Assuntos
Bradicinina/sangue , Cininogênios/sangue , Sepse/fisiopatologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Cuidados Críticos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Escores de Disfunção Orgânica , Estudos Prospectivos , Sepse/mortalidade , Sepse/patologia , Análise de Sobrevida , Adulto Jovem
5.
ACS Appl Mater Interfaces ; 10(47): 40443-40451, 2018 Nov 28.
Artigo em Inglês | MEDLINE | ID: mdl-30394728

RESUMO

The analysis of low-level protein biomarkers in serum is precluded by the presence of other highly abundant serum proteins. Hence, the preliminary removal of serum albumin along with other abundant proteins in serum (i.e., immunoglobulins, transferrin, haptoglobin, α-2-macroglobulin, and apolipoproteins) is often a requirement prior to any biomarker analysis. In this work, we take advantage of the low isoelectric points (pI's) of these highly abundant proteins to selectively deplete them from serum by extraction using functionalized amphiphilic polymeric nanoassemblies. The selectivity of extraction is dependent on the pI of the protein and the extraction pH, which holds true even for extremely complex protein mixtures like serum. High extraction capacity is achieved by optimizing the extraction conditions and is found to be comparable to currently available methods for depletion. Depletion of these abundant acidic proteins allows for the enhanced detection of higher pI proteins and enables a 3 orders of magnitude increase in detection sensitivity for a putative cancer biomarker, demonstrating the utility of these polymeric assemblies for enhancing the analysis of the serum proteome.


Assuntos
Ácidos/metabolismo , Proteínas Sanguíneas/metabolismo , Polímeros/química , Animais , Bradicinina/sangue , Bovinos , Galinhas , Humanos , Proteômica , Soroalbumina Bovina/metabolismo
6.
Mol Immunol ; 88: 116-124, 2017 08.
Artigo em Inglês | MEDLINE | ID: mdl-28641140

RESUMO

Revascularization of an amputated limb within 4-6h is essential to avoid extensive ischemia/reperfusion (I/R) injury leading to vascular leakage, edema and tissue necrosis. I/R injury is a pathological inflammatory condition that occurs during reperfusion of an organ or tissue after prolonged ischemia. It is characterized by a complex crosstalk between endothelial cell activation and the activation of plasma cascades. Vasculoprotective pharmacological intervention to prevent I/R injury might be an option to prolong the time window between limb amputation and successful replantation. We used C1-easterase inhibitor (C1-INH) in this study because of its known inhibitory effects on the activation of the complement, coagulation and kinin cascades. Forelimbs of 8 large white pigs were amputated, subjected to ischemia, and then reperfused with autologous whole blood. All limbs were exposed to 9h of cold ischemia at 4°C. After 2h of cold ischemia the limbs were either perfused with of C1-INH (1U/ml in hydroxyethyl starch, n=8) or hydroxyethyl starch alone (n=7). After completion of the 9-h ischemia period, all limbs were ex vivo perfused with heparinized autologous whole blood for 12h using a pediatric heart lung machine to simulate in vivo revascularization. Our results show that I/R injury in the control group led to a significant elevation of tissue deposition of IgG and IgM, complement C3b/c, C5b-9 and MBL. Also, activation of the kinin system was significantly increased, namely bradykinin in plasma, and expression of bradykinin receptors 1 and 2 in tissue. In addition, markers for endothelial integrity like expression of CD31, VE-cadherin and heparan sulfate proteoglycans were decreased in reperfused tissue. Limb I/R injury also led to activation of the coagulation cascade with a significant elevation of fibrin and thrombin deposition and increased fibrinogen-like protein-2 expression. C1-INH treated limbs showed much less activation of plasma cascades and better protection of endothelial integrity compared to the reperfused control limbs. In conclusion, the use of the cytoprotective drug C1-INH significantly reduced I/R injury by protecting the vascular endothelium as well as the muscle tissue from deposition of immunoglobulins, complement and fibrin.


Assuntos
Cotos de Amputação/irrigação sanguínea , Cotos de Amputação/patologia , Proteína Inibidora do Complemento C1/uso terapêutico , Neovascularização Fisiológica/efeitos dos fármacos , Traumatismo por Reperfusão/prevenção & controle , Amputação Cirúrgica , Animais , Bradicinina/sangue , Complemento C3b/imunologia , Complexo de Ataque à Membrana do Sistema Complemento/imunologia , Fibrina/metabolismo , Fibrinogênio/metabolismo , Derivados de Hidroxietil Amido/uso terapêutico , Imunoglobulina G/imunologia , Imunoglobulina M/imunologia , Receptores da Bradicinina/sangue , Traumatismo por Reperfusão/patologia , Suínos , Trombina/metabolismo
7.
Braz. j. med. biol. res ; 50(11): e6400, 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-888950

RESUMO

The aim of this study was to analyze the acute responses of bradykinin, insulin, and glycemia to exercise performed above and below lactate threshold (LT) in individuals with type 2 diabetes mellitus (T2D). Eleven participants with a diagnosis of T2D randomly underwent three experimental sessions 72 h apart: 1) 20 min of exercise performed at 120% of LT (120%LT), 2) 20 min of exercise performed at 80% of LT (80%LT), and 3) 20 min of control session. Blood glucose was analyzed before, during, and at 45 min post-exercise. Bradykinin and insulin were analyzed before and at 45 min post-exercise. Both exercise sessions elicited a parallel decrease in glucose level during exercise (P≤0.002), with a greater decrease being observed for 120%LT (P=0.005). Glucose decreased 22.7 mg/dL (95%CI=10.3 to 35, P=0.001) at the 45 min post-exercise recovery period for 80%LT and decreased 31.2 mg/dL (95%CI=18.1 to 44.4, P<0.001) for 120%LT (P=0.004). Insulin decreased at post-exercise for 80%LT (P=0.001) and control (P≤0.035). Bradykinin increased at 45 min post-exercise only for 80%LT (P=0.013), but was unrelated to the decrease in glucose (r=-0.16, P=0.642). In conclusion, exercise performed above and below LT reduced glycemia independently of insulin, but exercise above LT was more effective in individuals with T2D. However, these changes were unrelated to the increase in circulating bradykinin.


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Glicemia/análise , Bradicinina/sangue , Exercício Físico/fisiologia , Ácido Láctico/sangue , Diabetes Mellitus Tipo 2/sangue , Insulina/sangue , Consumo de Oxigênio/fisiologia , Fatores de Tempo , Análise de Variância , Resultado do Tratamento , Estatísticas não Paramétricas , Estudos Cross-Over , Diabetes Mellitus Tipo 2/fisiopatologia , Teste de Esforço , Frequência Cardíaca/fisiologia
8.
Curr Opin Allergy Clin Immunol ; 15(4): 383-91, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26106828

RESUMO

PURPOSE OF REVIEW: Hereditary angioedema (HAE) due to C1-inhibitor (C1-INH) deficiency (C1-INH-HAE) is a rare disease, with a reported prevalence of about 1 : 50 000. C1-INH-HAE causes disabling symptoms, which may be life-threatening if swelling affects upper airways. Diagnostic procedures are now well established and the role of bradykinin as the main mediator of plasma outflow eliciting angioedema formation has been clearly elucidated. RECENT FINDINGS: Increased understanding of the pathogenesis of C1-INH-HAE allowed in recent years the development of new drugs targeted to inhibit bradykinin synthesis (Ecallantide) or activity (Icatibant). At the same time, a recombinant C1-INH concentrate (Ruconest) was produced from the milk of transgenic rabbits and two plasma-derived C1-INHs (Berinert, Cinryze) underwent controlled trials to obtain marketing authorization. In 2012, an Italian network for C1-INH-HAE (ITACA) was established by physicians of 17 HAE reference centres to collect data from Italian patients and to homogenize and improve the diagnostic and therapeutic approach to the disease. SUMMARY: Although there is a widespread agreement on therapeutic goals and treatment of C1-INH-HAE acute attacks, different approaches to prophylaxis are still present among HAE experts. The clinical experience of ITACA on a large population of C1-INH-HAE patients followed for several years may help in identifying the most effective strategies for the management of the disease.


Assuntos
Angioedemas Hereditários , Proteínas Inativadoras do Complemento 1/uso terapêutico , Proteína Inibidora do Complemento C1/uso terapêutico , Peptídeos/uso terapêutico , Adulto , Angioedemas Hereditários/sangue , Angioedemas Hereditários/diagnóstico , Angioedemas Hereditários/tratamento farmacológico , Animais , Animais Geneticamente Modificados , Bradicinina/antagonistas & inibidores , Bradicinina/sangue , Humanos , Itália , Coelhos , Proteínas Recombinantes/uso terapêutico
9.
World J Gastroenterol ; 21(18): 5482-7, 2015 May 14.
Artigo em Inglês | MEDLINE | ID: mdl-25987770

RESUMO

AIM: To explore hemodynamics and vasoactive substance levels during renal vein congestion that occurs in the anhepatic phase of liver transplantation. METHODS: New Zealand rabbits received ligation of the hepatic pedicle, supra-hepatic vena cava and infra-hepatic vena cava [anhepatic phase group (APH); n = 8], the renal veins (RVL; n = 8), renal veins and hepatic pedicle [with the inferior vena cava left open) (RVHP; n = 8)], or a sham operation (SOP; n = 8). Hemodynamic parameters (systolic, diastolic, and mean arterial blood pressures) and the levels of serum bradykinin (BK) and angiotensin II (ANGII) were measured at baseline (0 min), and 10 min, 20 min, 30 min, and 45 min after the surgery. Correlation analyses were performed to evaluate the associations between hemodynamic parameters and levels of vasoactive substances. RESULTS: All experimental groups (APH, RVL, and RVHP) showed significant decreases in hemodynamic parameters (systolic, diastolic, and mean arterial blood pressures) compared to baseline levels, as well as compared to the SOP controls (P < 0.05 for all). In contrast, BK levels were significantly increased compared to baseline in the APH, RVL, and RVHP groups at all time points measured (P < 0.05 for all), whereas no change was observed in the SOP controls. There were no significant differences among the experimental groups for any measure at any time point. Further analyses revealed that systolic, diastolic, and mean arterial blood pressures were all negatively correlated with BK levels, and positively correlated with ANGII levels in the APH, RVL, and RVHP groups (P < 0.05 for all). CONCLUSION: In the anhepatic phase of orthotopic liver transplantation, renal vein congestion significantly impacts hemodynamic parameters, which correlate with serum BK and ANGII levels.


Assuntos
Angiotensina II/sangue , Bradicinina/sangue , Hemodinâmica , Transplante de Fígado/efeitos adversos , Circulação Renal , Veias Renais/cirurgia , Animais , Ligadura , Masculino , Coelhos , Veias Renais/fisiopatologia , Fatores de Tempo
10.
J Tradit Chin Med ; 35(2): 184-91, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25975051

RESUMO

OBJECTIVE: To observe the effects of Bushenwenyanghuayu decoction (BD), a Traditional Chinese Medicine (TCM), on the serum concentration of nerve growth factor (NGF) and bradykinin (BK), and protein and mRNA levels of NGF and bradykinin B1 receptor (BKB1R) in a mouse model of endometriosis dysmenorrhea. METHODS: Seventy-five experimental female BALB/c mice were randomly divided into five groups, 15 mice each: sham, model, BD high dose (61.67 g/kg), BD low dose (15.42 g/kg), and gestrinone (0.4 mg/kg) groups. All the mice except for those in the sham group underwent auto-transplantation surgery and were gavaged estradiol valerate (0.5 mg/kg, daily for 12 days) after surgery. On the 12th day, 1 h after administration, writhing response was induced by intraperitoneal injection of oxytocin at 2 U/mouse. The writhing frequency and latency were recorded and the volume of the ectopic foci was measured. The concentration of serum NGF and BK was detected by enzyme-linked immunosorbent assay, the protein expression of NGF and BKB1R was tested by immunohistochemistry and western blotting, and NGF and BKB1R mRNAs were detected by real-time PCR. RESULTS: Compared with the model group, the volume of the ectopic foci in the treatment groups was significantly lower (P < 0.01), the writhing frequency was decreased (P < 0.05), and the writhing latency was prolonged (P < 0.01). Compared with the sham group, serum NGF and BK levels in the model group were significantly increased (P < 0.01). There were positive correlations for writhing frequency among the NGF and BK groups (P < 0.01). The serum NGF and BK levels were significantly lower in the treatment groups than the model group (P < 0.05). The protein expression of NGF, BKB1R was significantly decreased in the treatment groups compared with the model group (P < 0.01). NGF and BKB1R mRNA expression was significantly decreased in the treatment groups compared with the model group (P < 0.01). CONCLUSION: NGF and BK/BKB1R may play an important role in the development of endometriosis-associated dysmenorrhea, and BD was found to inhibit the development of endometriosis and relieve dysmenorrhea by influencing NGF and BK/ BKB1R mRNA and protein levels.


Assuntos
Bradicinina/sangue , Medicamentos de Ervas Chinesas/administração & dosagem , Dismenorreia/tratamento farmacológico , Endometriose/tratamento farmacológico , Fator de Crescimento Neural/sangue , Receptor B1 da Bradicinina/sangue , Animais , Bradicinina/genética , Modelos Animais de Doenças , Dismenorreia/sangue , Dismenorreia/genética , Endometriose/sangue , Endometriose/genética , Feminino , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Fator de Crescimento Neural/genética , Receptor B1 da Bradicinina/genética
11.
Chem Immunol Allergy ; 100: 140-7, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24925394

RESUMO

Diseases which have been demonstrated to be caused by increased plasma levels of bradykinin all have angioedema as the common major clinical manifestation. Angioedema due to therapy with angiotensin-converting enzyme (ACE) inhibitors is caused by suppressed bradykinin degradation so that it accumulates. This occurs because ACE metabolizes bradykinin by removal of Phe-Arg from the C-terminus, which inactivates it. By contrast, angioedema due to C1 inhibitor deficiency (either hereditary types I and II, or acquired) is caused by bradykinin overproduction. C1 inhibitor inhibits factor XIIa, kallikrein and activity associated with the prekallikrein-HK (high-molecular-weight kininogen) complex. In its absence, uncontrolled activation of the plasma bradykinin cascade is seen once there has been an initiating stimulus. C4 levels are low in all types of C1 inhibitor deficiency due to the instability of C1 (C1r, in particular) such that some activated C1 always circulates and depletes C4. In the hereditary disorder, formation of factor XIIf (factor XII fragment) during attacks of swelling causes C4 levels to drop toward zero, and C2 levels decline. A kinin-like molecule, once thought to be a cleavage product derived from C2 that contributes to the increased vascular permeability seen in hereditary angioedema (HAE), is now thought to be an artifact, i.e. no such molecule is demonstrable. The acquired C1 inhibitor deficiency is associated with clonal disorders of B cell hyperreactivity, including lymphoma and monoclonal gammopathy. Most cases have an IgG autoantibody to C1 inhibitor which inactivates it so that the presentation is strikingly similar to type I HAE. New therapies for types I and II HAE include C1 inhibitor replacement therapy, ecallantide, a kallikrein antagonist, and icatibant, a B2 receptor antagonist. A newly described type III HAE has normal C1 inhibitor, although it is thought to be mediated by bradykinin, as is an antihistamine-resistant subpopulation of patients with 'idiopathic' angioedema. The mechanism(s) for the formation of bradykinin in these disorders is unknown.


Assuntos
Angioedema/etiologia , Bradicinina/metabolismo , Angioedema/tratamento farmacológico , Angioedema/imunologia , Angioedemas Hereditários/tratamento farmacológico , Angioedemas Hereditários/etiologia , Angioedemas Hereditários/imunologia , Inibidores da Enzima Conversora de Angiotensina/efeitos adversos , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Antifibrinolíticos/uso terapêutico , Bradicinina/análogos & derivados , Bradicinina/sangue , Complemento C1/antagonistas & inibidores , Complemento C1/genética , Complemento C1/metabolismo , Fator XII/metabolismo , Humanos , Calicreínas/antagonistas & inibidores , Calicreínas/metabolismo
12.
Anaesthesia ; 68(12): 1259-65, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24219252

RESUMO

We investigated changes in concentrations of interleukin-1ß, interleukin-6, tumour necrosis factor-α and bradykinin in blood during passage through a cell salvage device and a leucocyte depletion filter, with or without application of subatmospheric pressure across the filter. Blood samples from 19 healthy women undergoing scheduled caesarean section showed concentrations of cytokines and bradykinin in blood filtered under gravity flow that were equal to or significantly lower than those of pre-operative venous blood samples. They were also significantly lower than that in postoperative orthopaedic shed blood, which is commonly reinfused after orthopaedic surgery. A minority of samples taken from blood that had been filtered using subatmospheric pressure showed raised interleukin-6 concentrations. We suggest that use of a leucocyte depletion filter for cell-salvaged blood with gravity flow is likely to be safe with regard to concentrations of cytokines and bradykinin. However, this may not hold true for the filter used with subatmospheric pressure. If transfusion of salvaged blood using a leucocyte depletion filter seems to induce hypotension, elevation of interleukin-6 should be suspected.


Assuntos
Transfusão de Sangue Autóloga/métodos , Bradicinina/sangue , Citocinas/sangue , Filtração/instrumentação , Procedimentos de Redução de Leucócitos/instrumentação , Recuperação de Sangue Operatório/instrumentação , Adulto , Pressão Atmosférica , Transfusão de Sangue Autóloga/instrumentação , Cesárea , Feminino , Filtração/métodos , Humanos , Interleucina-1beta/sangue , Interleucina-6/sangue , Procedimentos de Redução de Leucócitos/métodos , Leucócitos , Recuperação de Sangue Operatório/métodos , Fator de Necrose Tumoral alfa/sangue
13.
Interact Cardiovasc Thorac Surg ; 17(4): 653-8, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23814135

RESUMO

OBJECTIVES: Remote ischaemic preconditioning (RIPC) may protect distant organs against ischaemia-reperfusion injury. We investigated the impact of RIPC on kinin receptor expression in neutrophils following RIPC in patients undergoing coronary artery bypass grafting (CABG). METHODS: Patients undergoing elective CABG with cardiopulmonary bypass (CPB) were randomized to RIPC (n = 15) or control (n = 15) groups. The study group underwent RIPC by inflation of a blood pressure cuff on the arm. Expression of kinin receptors, plasma concentrations of IL-6, IL-8, IL-10, TNF-α and neutrophil elastase were determined at baseline (before RIPC/sham), immediately before surgery (after RIPC/sham) and 30 min and 24 h after surgery. Plasma bradykinin levels were assessed before and after RIPC/sham, and at 30 min, 6, 12 and 24 h after surgery. Serum creatine kinase (CK), troponin I, C-reactive protein (CRP) and lactate levels were measured immediately prior to surgery and 30 min, 6, 12, 24 and 48 h after surgery. RESULTS: Kinin B2 receptor expression did not differ between the groups at baseline (pre-RIPC), but was significantly lower in the RIPC group than in the control group after RIPC/sham (P < 0.05). Expressions of both kinin B1 and B2 receptors were significantly down-regulated in the RIPC group, and this persisted to 24 h after surgery (P < 0.001). Neutrophil elastase levels were significantly increased after surgery. There were no differences in CK, CRP, cytokine, lactate or troponin I levels between the groups. CONCLUSIONS: RIPC down-regulated the expression of kinin B1 and B2 receptors in neutrophils of patients undergoing CABG.


Assuntos
Ponte de Artéria Coronária , Precondicionamento Isquêmico/métodos , Neutrófilos/metabolismo , Receptor B1 da Bradicinina/metabolismo , Traumatismo por Reperfusão/prevenção & controle , Extremidade Superior/irrigação sanguínea , Idoso , Biomarcadores/sangue , Bradicinina/sangue , Proteína C-Reativa/metabolismo , Ponte Cardiopulmonar , Ponte de Artéria Coronária/efeitos adversos , Creatina Quinase/sangue , Citocinas/sangue , Método Duplo-Cego , Regulação para Baixo , Feminino , Humanos , Ácido Láctico/sangue , Elastase de Leucócito/sangue , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Receptor B2 da Bradicinina/metabolismo , Fluxo Sanguíneo Regional , Traumatismo por Reperfusão/sangue , Traumatismo por Reperfusão/etiologia , Fatores de Tempo , Torniquetes , Resultado do Tratamento , Troponina I/sangue , Austrália Ocidental
14.
Expert Rev Clin Immunol ; 8(1): 25-32, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22149337

RESUMO

Hereditary angioedema (HAE) is a rare genetic disorder characterized by unpredictable, episodic, incapacitating attacks of well-demarcated angioedema in the absence of urticaria and pruritus. HAE is due to deficient or dysfunctional C1-esterase inhibitor activity, which results in unopposed activation of plasma kallikrein, resulting in increased levels of bradykinin. Ecallantide is a potent and specific plasma kallikrein inhibitor approved for the treatment of acute attacks of HAE affecting any anatomic site. In Phase III clinical trials, subcutaneously administered ecallantide demonstrated significant, rapid and durable symptom relief. Ecallantide was effective for all attack types, including potentially life-threatening laryngeal attacks. The main safety concern is potentially serious hypersensitivity reactions, including anaphylaxis. Ecallantide represents an important treatment option for the management of acute attacks of HAE.


Assuntos
Angioedemas Hereditários/tratamento farmacológico , Doenças da Laringe/tratamento farmacológico , Peptídeos/administração & dosagem , Doença Aguda , Adulto , Angioedemas Hereditários/sangue , Angioedemas Hereditários/genética , Bradicinina/sangue , Bradicinina/genética , Proteína Inibidora do Complemento C1/genética , Método Duplo-Cego , Feminino , Humanos , Injeções Subcutâneas , Calicreínas/sangue , Calicreínas/genética , Doenças da Laringe/sangue , Doenças da Laringe/genética , Masculino , Pessoa de Meia-Idade
15.
Analyst ; 137(4): 1024-30, 2012 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-22193368

RESUMO

Reverse-micelle forming amphiphilic homopolymers with carboxylic acid and quaternary amine substituents are used to selectively enrich biomarker peptides and protein fragments from human serum prior to matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS) analysis. After depletion of human serum albumin (HSA) and immunoglobulin G (IgG), low abundance peptide biomarkers can be selectively enriched and detected by MALDI-MS at clinically relevant concentrations by using the appropriate homopolymer(s) and extraction pH value(s). Three breast cancer peptide biomarkers, bradykinin, C4a, and ITIH(4), were chosen to test this new approach, and detection limits of 0.5 ng mL(-1), 0.08 ng mL(-1), and 0.2 ng mL(-1), respectively, were obtained. In addition, the amphiphilic homopolymers were used to detect prostate specific antigen (PSA) at concentrations as low as 0.5 ng mL(-1) by targeting a surrogate peptide fragment of this protein biomarker. Selective enrichment and sensitive MS detection of low abundance peptide/protein biomarkers by these polymeric reverse micelles should be a sensitive and straightforward approach for biomarker screening in human serum.


Assuntos
Proteínas Sanguíneas/análise , Complemento C4a/análise , Fragmentos de Peptídeos/sangue , Antígeno Prostático Específico/sangue , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Biomarcadores/sangue , Biomarcadores/química , Proteínas Sanguíneas/química , Bradicinina/sangue , Bradicinina/química , Ácidos Carboxílicos/química , Complemento C4a/química , Feminino , Glicoproteínas/sangue , Glicoproteínas/química , Humanos , Masculino , Micelas , Fragmentos de Peptídeos/química , Antígeno Prostático Específico/química , Proteínas Secretadas Inibidoras de Proteinases/sangue , Proteínas Secretadas Inibidoras de Proteinases/química , Compostos de Amônio Quaternário/química , Sensibilidade e Especificidade , Tensoativos/química
16.
Anal Biochem ; 417(2): 174-81, 2011 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-21756868

RESUMO

Although most time-of-flight (TOF) mass spectrometers come equipped with vacuum matrix-assisted laser desorption/ionization (MALDI) sources, the atmospheric pressure MALDI (API-MALDI) source is an attractive option because of its ability to be coupled to a wide range of analyzers. This article describes the use of an API-MALDI source coupled to a TOF mass spectrometer for evaluation of the effects of medium- and long-term storage on peptidomic profiles of cryopreserved serum samples from healthy women. Peptides were purified using superparamagnetic beads either from fresh sera or after serum storage at -80°C for 18 months or at -20°C for 8 years. Data were preprocessed using newly developed bioinformatic tools and then were subjected to statistical analysis and class prediction. The analyses showed a dramatic effect of storage on the abundance of several peptides such as fibrinopeptides A and B, complement fractions, bradykinin, and clusterin, indicated by other authors as disease biomarkers. Most of these results were confirmed by shadow clustering analysis, able to classify each sample in the correct group. In addition to demonstrating the suitability of the API-MALDI technique for peptidome profiling studies, our data are of relevance for retrospective studies that involve frozen sera stored for many years in biobanks.


Assuntos
Pressão Atmosférica , Criopreservação , Neoplasias/sangue , Peptídeos/sangue , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Bradicinina/sangue , Clusterina/sangue , Proteínas do Sistema Complemento/análise , Feminino , Fibrinopeptídeo A/análise , Fibrinopeptídeo B/análise , Humanos , Manejo de Espécimes
17.
Proteomics ; 11(13): 2727-37, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21630454

RESUMO

We have recently developed a new target plate (BLOTCHIP®) for MALDI-MS. An advantage of this procedure is that it does not require the lowering of protein concentrations in test samples prior to analysis. Accordingly, this new technology enables the detection of peptides present in blood samples, including those that would otherwise be adsorbed to abundant blood proteins and would thus escape detection. Using this technology, we analyzed the peripheral blood of patients with pregnancy-induced hypertension (PIH; the most common serious complication of pregnancy) to test a potential utility of the technology for monitoring of the pathophysiological status. In the present study, we found 23 characteristic peptides for PIH in the blood serum of pregnant women. Offline LC-MALDI MS/MS identified 7 of the 23 peptides as fragments derived from kininogen-1 (three peptides), fibrinogen-α, complement component C4-A/B, α-2-HS-glycoprotein and inter-α-trypsin inhibitor heavy chain H4. 2-D scatter plots with combinations of the peptides found in the present study can be grouped for pregnant women with/without PIH, which would be satisfactory reflected for their status. Additionally, the levels of most of these peptides found were significantly decreased by albumin/IgG depletion prior to BLOTCHIP® analysis in accordance with conventional proteomics procedures. These results indicated that BLOTCHIP® analysis can be applied for discovery study of PIH biomarker candidates.


Assuntos
Biomarcadores/sangue , Proteínas Sanguíneas/análise , Hipertensão Induzida pela Gravidez/sangue , Hipertensão Induzida pela Gravidez/fisiopatologia , Peptídeos/análise , Proteoma/análise , Proteômica/métodos , Adulto , Bradicinina/sangue , Feminino , Humanos , Peptídeos/genética , Gravidez , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Espectrometria de Massas em Tandem/métodos
18.
Mol Cell Neurosci ; 45(2): 101-7, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20558294

RESUMO

The use of the peptidase neprilysin (NEP) as a therapeutic for lowering brain amyloid burden is receiving increasing attention. We have previously demonstrated that peripheral expression of NEP on the surface of hindlimb muscle lowers brain amyloid burden in a transgenic mouse model of Alzheimer's disease. In this study we now show that using adeno-associated virus expressing a soluble secreted form of NEP (secNEP-AAV8), NEP secreted into plasma is effective in clearing brain Abeta. Soluble NEP expression in plasma was sustained over the 3-month time period it was measured. Secreted NEP decreased plasma Abeta by 30%, soluble brain Abeta by approximately 28%, insoluble brain Abeta by approximately 55%, and Abeta oligomersby 12%. This secNEP did not change plasma levels of substance P or bradykinin, nor did it alter blood pressure. No NEP was detected in CSF, nor did the AAV virus produce brain expression of NEP. Thus the lowering of brain Abeta was due to plasma NEP which altered blood-brain Abeta transport dynamics. Expressing NEP in plasma provides a convenient way to monitor enzyme activity during the course of its therapeutic testing.


Assuntos
Peptídeos beta-Amiloides/metabolismo , Encéfalo/metabolismo , Neprilisina/sangue , Animais , Pressão Sanguínea , Barreira Hematoencefálica/enzimologia , Bradicinina/sangue , Química Encefálica , Dependovirus , Humanos , Camundongos , Neprilisina/genética , Substância P/sangue
19.
J Proteome Res ; 9(8): 3781-8, 2010 Aug 06.
Artigo em Inglês | MEDLINE | ID: mdl-20557135

RESUMO

Many proteins have been proposed as potential biomarkers for breast cancer. Yet, validation of their discriminative value using quantitative methods has scarcely been performed. In this study, we investigated the discriminative value of six peptides that were previously proposed to be generated by breast cancer specific exoproteases: bradykinin, des-Arg(9)-bradykinin, Hyp(3)-bradykinin, and fragments of fibrinogen alpha-chain (Fib-alpha ([605-629])), complement component 4a (C4a ([1337-1350])), and interalpha trypsin inhibitor heavy chain 4 (ITIH4 ([666-687])). Their absolute serum concentrations were measured with a completely validated liquid chromatography-tandem mass spectrometric assay (LC-MS/MS) and compared between 62 newly diagnosed breast cancer patients and 62 controls matched for age and sample storage duration. Both ITIH4 ([666-687]) and des-Arg(9)-bradykinin showed statistically significantly higher median concentrations in breast cancer samples than in matched control samples. Additionally, we analyzed serum samples collected after surgical removal of the tumor, in which median ITIH4 ([666-687]) and des-Arg(9)-bradykinin concentrations were significantly decreased and not statistically significantly different from concentrations in the controls anymore. In a combined analysis, ITIH4 (666-687]) and des-Arg(9)-bradykinin independently contributed to the discrimination between cases and controls. In this study, we confirmed that the exoprotease breakdown peptides, ITIH4 (666-687]) and des-Arg(9)-bradykinin, differed between breast cancer cases and controls, supporting the potential of degradome markers for the diagnosis of breast cancer.


Assuntos
Biomarcadores Tumorais/sangue , Proteínas Sanguíneas , Neoplasias da Mama/sangue , Neoplasias da Mama/diagnóstico , Idoso , Sequência de Aminoácidos , Área Sob a Curva , Proteínas Sanguíneas/genética , Bradicinina/sangue , Bradicinina/genética , Estudos de Casos e Controles , Cromatografia Líquida , Complemento C4a/análise , Complemento C4a/genética , Feminino , Fibrinogênio/análise , Fibrinogênio/genética , Glicoproteínas/sangue , Glicoproteínas/genética , Humanos , Pessoa de Meia-Idade , Dados de Sequência Molecular , Países Baixos , Proteínas Secretadas Inibidoras de Proteinases/sangue , Proteínas Secretadas Inibidoras de Proteinases/genética , Proteômica/métodos , Espectrometria de Massas em Tandem
20.
Curr Diab Rep ; 10(4): 270-5, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20535647

RESUMO

Recent proteomic studies have identified components of the kallikrein kinin system, including plasma kallikrein, factor XII, and kininogen, in vitreous obtained from individuals with advanced diabetic retinopathy. In rodent models, activation of plasma kallikrein in vitreous increases retinal vascular permeability; whereas inhibition of the kallikrein kinin system reduces retinal leakage induced by diabetes and hypertension. These findings suggest that intraocular activation of the plasma kallikrein pathway may contribute to excessive retinal vascular permeability that can lead to diabetic macular edema. The kallikrein kinin system contains two separate and independently regulated serine proteases that generate bradykinin peptides: plasma kallikrein and tissue kallikrein. Tissue kallikrein is expressed in the retina and ciliary body, where it has been implicated in exerting autocrine or paracrine effects via bradykinin receptors that are colocalized in these tissues. Emerging evidence suggests that plasma kallikrein inhibitors may provide a new therapeutic opportunity to reduce retinal vascular permeability.


Assuntos
Retinopatia Diabética/sangue , Retinopatia Diabética/fisiopatologia , Edema Macular/sangue , Edema Macular/metabolismo , Calicreína Plasmática/metabolismo , Animais , Bradicinina/sangue , Bradicinina/metabolismo , Retinopatia Diabética/metabolismo , Humanos , Sistema Calicreína-Cinina/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA